Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Taro Receives FDA Approval For Sulfacetamide Sodium Topical Suspension ANDA
Taro Pharmaceutical Industries Ltd. ("Taro," the "Company," Pink Sheets: TAROF) reported that its Canadian manufacturing site has received approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Sulfacetamide Sodium Topical Suspension USP, 10% (lotion) ("sulfacetamide sodium lotion").

Washington Post Examines Lack Of Information About Stillbirths, Bill To Expand Data Collection
Centers for Disease Control and Prevention data show that stillbirth occurs in about one in every 160 pregnancies in the U.S., but physicians rarely warn pregnant women or their partners about the possibility, Washington Post staff writer Alan Goldenbach writes in an article discussing his experience when his wife"s pregnancy ended in stillbirth. In the U.S., the clinical definition for stillbirth is the death of a fetus after 20 weeks" gestation or weighing 350 grams if the age is unknown.There are about 26,000 stillbirths annually in the U.S., according to CDC. Goldenbach writes that this is "10 times the number of deaths attributed to sudden infant death syndrome, which has been identified as a key public health issue, and four times the incidence rate of Down syndrome, for which prenatal testing has become almost ritual." He continues that many doctors told him and his wife "that they don"t see any point in discussing stillbirth, that it"s a catch-all term for an event, and one that is frequently unexplained." Doctors contend that if they knew the causes or signs of stillbirth, they would warn patients or take preventive action, he adds. Noting that awareness of SIDS spurred research into preventive measures, Goldenbach writes that "[w]e can"t know if improved technology or more stringent standards of monitoring can lower stillbirth rates unless we do the research."Ruth Fretts, an assistant professor of obstetrics and gynecology at Harvard Medical School and chair of the scientific committee for the International Stillbirth Alliance, said, "It"s a trade-off -- you are going to frighten a lot of people" by discussing stillbirths. According to Fretts" research, the leading cause of fetal death after 28 weeks" gestation is an unexplained . Goldenbach writes, "Several doctors told us privately that many ob-gyns fear charges of malpractice following a stillbirth, leading them to avoid citing a cause of death."Stillbirth Legislation in Development Sen. Frank Lautenberg (D-N.J.) is drafting legislation similar to a stillbirth prevention bill that then-Sen. Barack Obama (D-Ill.) introduced in June 2008. According to s familiar with the bill, it will be brought to the Senate floor before the August recess. The legislation will expand stillbirth registries already in operation in Iowa and metropolitan Atlanta. The bill"s supporters hope to have as many as 12 states participating in the registry and installing a standard protocol for data collection after each stillbirth. Another provision would create a campaign to increase public awareness and strengthen grief support services, Goldenbach writes (Goldenbach, Washington Post, 7/6).
News of the day
Making Faces: Robot Learns To Smile And Frown
A hyper-realistic Einstein robot at the University of California, San Diego has learned to smile and make facial expressions through a process of self-guided learning. The UC San Diego researchers used machine learning to "empower" their robot to learn to make realistic facial expressions.
Health Insurance

Two Drug-Related Legislative Plans Pose Problems For Stakeholders

"The Senate dealt a blow to the drug lobby Thursday by voting to permit people in the United States to order lower-cost drugs from Canada over the Internet," the Associated Press/Arizona Republic reports. The drugs in question are often made in the U.S., and then sold abroad for lower prices than at home because because of government policies in many other countries. The bill would make it legal to re-import those drugs more readily. The drug provision passed as an amendment to a Department of Homeland Security funding bill and was introduced by Republican Louisianna Sen. David Vitter (Taylor, 7/9). Meanwhile, "Television networks and other media companies are rushing to try to quash a plan they say amounts to a tax on advertisements for prescription drugs," the Wall Street Journal reports. "The change for drug ads is on a short list of new taxes that House Ways and Means Committee members want to use to pay for a $1 trillion overhaul of the health-care system. [Rep. Charles Rangel, D-N.Y.,] said earlier this year that denying the deduction to pharmaceutical firms would raise $37 billion over 10 years" (Vaughan, 7/10). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009